| JOAN CARLES FONT | PRIME PEOPLE
Has the business needed to adapt to the changes in the market? mesoestetic has been able to progress strategically in time because of its international mission. In this regard, we have barely been affected by the crisis. The aesthetic sector has continued to grow in terms of market share. Image, wellbeing, and health are three very important areas of life itself and nowadays people take good care of mesoestetic
themselves. currently
operates in a fragmented market with many other, less consolidated companies. Fortunately, the market is self-regulating. The crisis has distilled the market, while customers are able to choose the aesthetic products they consume according to their own criteria. Also, in order to stay at the forefront of
An in-depth
understanding of the markets and hard work in collaboration with our suppliers are the important factors that will drive our growth.
the advances in the field of cosmetic science, we invest more than 40% of our revenue each year in product development and in research to improve our formulas and manufacturing processes. In 2012, the company invested
facilities
€23 million in new headquarters. With over 8500 m2 features
of space, our state-of-the-art
technology and include three pharmaceutical manufacturing lines for topical drugs, sterile medical products, and cosmeceuticals; an advanced analytical control laboratory; R&D and quality control departments; and a large logistic warehouse.
How long have you been working to get mesoestetic into the Chinese market? Finding the right partner — which is especially critical to succeed in China — and registering our products has taken a number of years. This process is expected to be totally complete by the end of the third quarter 2013. To enter the Chinese market is a
strategic move for the company because China is a market with enormous potential for growth, especially in the aesthetics sector. The exclusive distribution agreement that we signed includes opening around 300 points of sale in the country, including beauty salons, hotel clinics, and spas.
prime-journal.com | October 2013
You currently sell your products in more than 60 countries. Do you find different markets favour different products? I think they absolutely do. Our 5-year plan sets out the approaches and strategies we have adopted by country and zone. Most of our products are universally applicable, although there are some more specific examples, such as Ultimate W+, a range which naturally has more potential in Asia than in African countries, given that it is a whitening product. It does not have much of a lightening effect on black skin but it is effective on white, Asian skin. We tailor our strategy according to whether we are working with countries in northern or southern Europe, Latin America, Asia, or Africa.
What would you say have been the significant successes
you’ve witnessed since starting the company? Our greatest success has been to develop our range of mesotherapy products. There were a lot of difficulties involved in creating it, but at last we have done it and we can confirm that we were the first in the market. Our perseverance to succeed in this task and overcome the legal obstacles has been essential. With 11 products, our mesohyal™ range
is currently the most extensive range of injectable products with the CE mark that addresses the signs and symptoms of skin ageing as well as unsightly figure concerns. The products in the mesohyal™ range can be used alone or combined to create made-to-measure cocktails. This makes mesotherapy a highly targeted option for addressing each patient's specific
aesthetic disorders. mesoestetic Pharma Group is a Spanish pharmaceutical company that manufactures intradermal medical devices with the CE mark, which gives patients and professionals a quality and safety guarantee and peace of mind that these are supervised products with proven efficacy.
What challenges have you had to overcome to get mesoestetic to where it is today? Basically, to be committed and enthusiastic about what you do every day and to be keen to work. These are part of the DNA of a winner. We have to enjoy what we do and be happy with our lives and at work, which is where we spend most of our time. There's no point in getting up every day and not being happy with what you do or what you have. We have to be tenacious to make our products grow.
How does mesoestetic Pharma Group continue to grow? An in-depth understanding of the markets and hard work in collaboration with our suppliers are the important factors that will drive our growth. That's the only way we can respond to market needs. Good business management is also important, and this is a job that we share with our different distributors. Not to forget the investments in R&D to develop new projects and solutions, and to enable us to stay at the forefront of advances in cosmetic medicine.
Further information
www.mesoestetic.com, AMEC Stand: C23
❚
81
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100